Please login to the form below

Not currently logged in
Email:
Password:

depression

This page shows the latest depression news and features for those working in and with pharma, biotech and healthcare.

Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3

Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3

Biogen and Sage signed a $3.1bn deal last year to jointly develop potential depression therapies. ... These results represent hope and positive progress for the more than 250 million patients worldwide who are estimated to live with depression.

Latest news

More from news
Approximately 28 fully matching, plus 301 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 39 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....